Clinical Trial Update: Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effects of eicosapentaenoic acid on endothelial function in adults with type 2 diabetes and coronary artery disease was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes, Coronary Artery Disease | Phase 3 | Status: TERMINATED | Results posted: 2018-06-06